{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T11:21:08Z","timestamp":1649157668223},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,2,6]],"date-time":"2018-02-06T00:00:00Z","timestamp":1517875200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s00393-017-0415-0","type":"journal-article","created":{"date-parts":[[2018,2,6]],"date-time":"2018-02-06T05:02:03Z","timestamp":1517893323000},"page":"735-740","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Myositisspezifische Antik\u00f6rper bei juveniler Dermatomyositis"],"prefix":"10.1007","volume":"77","author":[{"given":"K.","family":"Eising","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Peitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Unterwalder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Meisel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Horneff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,6]]},"reference":[{"key":"415_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/ar3275","volume":"13","author":"ZE Betteridge","year":"2011","unstructured":"Betteridge ZE, Gunawardena H, McHugh NJ (2011) Novel autoantibodies and clinical phenotypes in adult and juvenile myositis. Arthritis Res Ther 13:209","journal-title":"Arthritis Res Ther"},{"key":"415_CR2","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N\u00a0Engl J Med 292:344\u2013347","journal-title":"N Engl J Med"},{"key":"415_CR3","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1093\/rheumatology\/kel025","volume":"45","author":"VE Brown","year":"2006","unstructured":"Brown VE et\u00a0al (2006) An international consensus survey of the diagnostic criteria for juvenile dermatomyositis (JDM). Rheumatology (Oxford) 45:990\u2013993","journal-title":"Rheumatology (Oxford)"},{"key":"415_CR4","first-page":"1794","volume":"23","author":"BM Feldman","year":"1996","unstructured":"Feldman BM, Reichlin M, Laxer RM, Targoff IN, Stein LD, Silverman ED (1996) Clinical significance of specific autoantibodies in juvenile dermatomyositis. J\u00a0Rheumatol 23:1794\u20131797","journal-title":"J Rheumatol"},{"key":"415_CR5","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1016\/S0140-6736(08)60955-1","volume":"371","author":"BM Feldmann","year":"2008","unstructured":"Feldmann BM, Rider LG, Reed AM, Pachmann LM (2008) Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood. Lancet 371:2201\u20132212","journal-title":"Lancet"},{"key":"415_CR6","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1093\/rheumatology\/kep078","volume":"48","author":"H Gunawardena","year":"2009","unstructured":"Gunawardena H, Betteridge Z, McHugh NJ (2009) Myositis-specific autoantibodies: their clinical and pathogenic significance in desease expression. Rheumatology (Oxford) 48:607\u2013612","journal-title":"Rheumatology (Oxford)"},{"key":"415_CR7","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1002\/art.24547","volume":"60","author":"H Gunawardena","year":"2009","unstructured":"Gunawardena H, Wedderburn LR, Chinoy H et al (2009) Juvenile Dermatomyositis Research Group, UK and Ireland: autoantibodies to a\u00a0140-kd protein in juvenile dermatomyositis are associated with calcinosis. Arthritis Rheum 60:1807\u20131814","journal-title":"Arthritis Rheum"},{"key":"415_CR8","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1093\/rheumatology\/kem359","volume":"47","author":"H Gunarwardena","year":"2008","unstructured":"Gunarwardena H, Wedderburn LR, North J, Betteridge Z, Dunphy J, Chinoy H et\u00a0al (2008) Clinical associations of autoantibodies to a\u00a0p155\/140\u202fkDa doublet protein in juvenile dermatomyositis. Rheumatology (Oxford) 47:324\u2013328","journal-title":"Rheumatology (Oxford)"},{"key":"415_CR9","doi-asserted-by":"publisher","first-page":"20611","DOI":"10.1074\/jbc.M201440200","volume":"277","author":"Y Kimura","year":"2002","unstructured":"Kimura Y, Sakai F, Nakano O et al (2002) The newly identified human nuclear protein NXP-2 possesses three distinct domains, the nuclear matrix-binding, RNA-binding and coiled-coil domains. J\u00a0Biol Chem 277:20611\u201320617","journal-title":"J Biol Chem"},{"issue":"5","key":"415_CR10","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1093\/rheumatology\/keu385","volume":"54","author":"N Kobayashi","year":"2015","unstructured":"Kobayashi N, Takezaki S, Kobayashi I, Iwata N, Mori M, Nagai K, Nakano N, Miyoshi M, Kinjo N, Murata T, Masunaga K, Umebayashi H, Imagawa T, Agematsu K, Sato S, Kuwana M, Yamada M, Takei S, Yokota S, Koike K, Ariga T (2015) Clinical and laboratory features of fatal rapidly progressive interstitial lung disease associated with juvenile dermatomyositis. Rheumatology (Oxford) 54(5):784\u2013791","journal-title":"Rheumatology (Oxford)"},{"key":"415_CR11","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1097\/00005792-199111000-00002","volume":"70","author":"LA Love","year":"1991","unstructured":"Love LA, Leff RL, Fraser DD et al (1991) A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore) 70:360\u2013374","journal-title":"Medicine (Baltimore)"},{"key":"415_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/art.40320","author":"IE Lundberg","year":"2017","unstructured":"Lundberg IE et\u00a0al (2017) 2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Arthritis Rheumatol. \n                    https:\/\/doi.org\/10.1002\/art.40320","journal-title":"Arthritis Rheumatol"},{"key":"415_CR13","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nrneurol.2011.63","volume":"7","author":"AL Mammen","year":"2011","unstructured":"Mammen AL (2011) Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis. Nat Rev Neurol 7:343\u2013354","journal-title":"Nat Rev Neurol"},{"key":"415_CR14","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1002\/art.11122","volume":"49","author":"EP Mendez","year":"2003","unstructured":"Mendez EP et\u00a0al (2003) US incidence of juvenile dermatomyositis, 1995\u20131998: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Registry. Arthritis Rheum 49:300\u2013305","journal-title":"Arthritis Rheum"},{"key":"415_CR15","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1097\/MPH.0b013e3181bf29a2","volume":"32","author":"P Morris","year":"2010","unstructured":"Morris P, Dare J (2010) Juvenile dermatomyositis as a\u00a0paraneoplastic phenomenon: an update. J\u00a0Pediatr Hematol Oncol 32:189\u2013191","journal-title":"J Pediatr Hematol Oncol"},{"key":"415_CR16","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/pde.13013","volume":"34","author":"EJ Oberle","year":"2017","unstructured":"Oberle EJ, Bayer ML, Chiu YE, Co DO (2017) How often are pediatric patients with clinically amyopathic dermatomyositis truly amyopathic? Pediatr Dermatol 34:50\u201357","journal-title":"Pediatr Dermatol"},{"key":"415_CR17","doi-asserted-by":"publisher","first-page":"9507","DOI":"10.1073\/pnas.83.24.9507","volume":"83","author":"WH Reeves","year":"1986","unstructured":"Reeves WH, Nigam SK, Blobel G (1986) Human autoantibodies reactive with signal-recognition particle. Proc Natl Acad Sci Usa 83:9507\u20139570","journal-title":"Proc Natl Acad Sci Usa"},{"key":"415_CR18","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1002\/art.1780371019","volume":"37","author":"LG Rider","year":"1994","unstructured":"Rider LG, Miller FW, Targoff IN, Sherry DD, Samayoa E, Lindahl M, Wener MH, Pachman LM, Plotz PH (1994) A broadened spectrum of juvenile myositis. Myositis-specific autoantibodies in children. Arthritis Rheum 37:1534\u20131538","journal-title":"Arthritis Rheum"},{"key":"415_CR19","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/joim.12444","volume":"280","author":"LG Rider","year":"2016","unstructured":"Rider LG, Nistala K (2016) The juvenile idiopathic inflammatory myopathies: pathogenesis, clinical and autoantibody phenotypes, and outcomes. J\u00a0Intern Med 280:24\u201338","journal-title":"J Intern Med"},{"key":"415_CR20","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1097\/MD.0b013e31829d08f9","volume":"92","author":"LG Rider","year":"2013","unstructured":"Rider LG, Shah M, Mamyrova G, Huber AM, Rice MM, Targoff IN, Miller FW (2013) Childhood Myositis Heterogeneity Collaborative Study Group. The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies. Medicine (Baltimore) 92:223\u2013243","journal-title":"Medicine (Baltimore)"},{"key":"415_CR21","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/MD.0b013e31827f264d","volume":"92","author":"M Shah","year":"2013","unstructured":"Shah M, Mamyrova G, Targoff IN et\u00a0al (2013) The clinical phenotypes of the juvenile idiopathic inflammatory myopathies. Medicine (Baltimore) 92:25\u201341","journal-title":"Medicine (Baltimore)"},{"key":"415_CR22","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1093\/rheumatology\/34.8.732","volume":"34","author":"DP Symmons","year":"1995","unstructured":"Symmons DP, Sills JA, Davis SM (1995) The incidence of juvenile dermatomyositis: results from a\u00a0nation-wide study. Br J Rheumatol 34:732\u2013736","journal-title":"Br J Rheumatol"},{"key":"415_CR23","volume-title":"Clinical differences between adult and juvenile dermatomyositis associated with anti-NXP2 autoantibodies","author":"S Tansley","year":"2012","unstructured":"Tansley S, Betteridge Z, Gunawardena H et al (2012) Clinical differences between adult and juvenile dermatomyositis associated with anti-NXP2 autoantibodies. ACR, Atlanta (abstract)"},{"key":"415_CR24","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1007\/s11926-014-0464-1","volume":"16","author":"SL Tansley","year":"2014","unstructured":"Tansley SL, McHugh NJ (2014) Myositis specific and associated autoantibodies in the diagnosis and management of juvenile and adult idiopathic inflammatory myopathies. Curr Rheumatol Rep 16:464","journal-title":"Curr Rheumatol Rep"},{"key":"415_CR25","first-page":"787","volume":"56","author":"IN Targoff","year":"2007","unstructured":"Targoff IN, Trieu EP, Levy-Neto M, Fertig N, Oddis CV (2007) Sera with autoantibodies to the MJ antigen react with NXP2. Arthritis Rheum 56:787","journal-title":"Arthritis Rheum"},{"key":"415_CR26","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1093\/nar\/29.12.2517","volume":"29","author":"HB Wang","year":"2001","unstructured":"Wang HB, Zhang Y (2001) Mi2, an auto-antigen for dermatomyositis, is an ATP-dependent nucleosome remodeling factor. Nucleic Acids Res 29:2517\u20132521","journal-title":"Nucleic Acids Res"},{"key":"415_CR27","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1093\/rheumatology\/kem265","volume":"46","author":"LR Wedderburn","year":"2007","unstructured":"Wedderburn LR, McHugh NJ, Chinoy H, Cooper RG, Salway F, Ollier WE, McCann LJ, Varsani H, Dunphy J, North J, Davidson JE Juvenile Dermatomyositis Research Group (JDRG) (2007) HLA class II haplotype and autoantibody associations in children with juvenile dermatomyositis and juvenile dermatomyositis-scleroderma overlap. Rheumatology (Oxford) 46:1786\u20131791","journal-title":"Rheumatology (Oxford)"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-017-0415-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-017-0415-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-017-0415-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T19:47:54Z","timestamp":1549396074000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-017-0415-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,6]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["415"],"URL":"https:\/\/doi.org\/10.1007\/s00393-017-0415-0","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,6]]},"assertion":[{"value":"6 February 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"K.\u00a0Eising, J.\u00a0Peitz, N.\u00a0Unterwalder, C.\u00a0Meisel und G.\u00a0Horneff geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren. Alle Patienten, die \u00fcber Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts zu identifizieren sind, haben hierzu ihre schriftliche Einwilligung gegeben.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}